Tirzepatide 40mg – Dual GLP-1/GIP Agonist Peptide

Tirzepatide 40mg is a high-purity research peptide known for its dual incretin receptor activity. This compound engages both GLP-1 and GIP receptors, making it a valuable tool for exploring multi-receptor signaling pathways in metabolic research. Supplied as a lyophilized powder with ≥99% purity, Tirzepatide 40mg provides investigators with a consistent reference peptide for controlled laboratory applications.

• Third-Party Lab Verified
• Mannitol-Free Preparation
• Fast, Discreet Shipping

Why Choose Tirzepatide 30mg?

Dual Incretin Mechanism

Engages GLP-1 & GIP Pathways: Tirzepatide interacts with both GLP-1 and GIP receptors, enabling researchers to study the combined influence of these incretin signals. This dual agonist activity makes it suitable for comparative experiments against single-pathway peptides.

Mechanistic Insights

Receptor-Level Effects: Laboratory studies frequently employ Tirzepatide to evaluate downstream effects of GLP-1 and GIP activation, such as signal transduction, endocrine cross-talk, and nutrient sensing. Its dual activity provides opportunities to assess how overlapping incretin pathways contribute to metabolic regulation in experimental models.

Research-Grade Purity

≥99% Pure & Filler-Free: Each batch is HPLC-verified and mass-spec confirmed, with no fillers or excipients. This ensures reliable, reproducible results across laboratory assays and long-term projects.

Versatile Applications

Broad Research Utility: Tirzepatide’s unique profile makes it applicable for studies in receptor pharmacology, peptide half-life extension, and comparative incretin biology. Its engineered long-acting properties (via fatty acid conjugation) allow evaluation of extended peptide activity in controlled preclinical settings.

What Is Tirzepatide?

Tirzepatide is a synthetic 39–amino acid peptide designed as a dual agonist at the glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. This dual mechanism has made Tirzepatide a focal point of research into incretin biology, allowing investigators to explore the interactions of these hormonal pathways under laboratory conditions.

In research contexts, Tirzepatide is applied to:

• Receptor pharmacology – studying GLP-1 and GIP receptor activation and signal transduction.
• Comparative incretin biology – benchmarking dual agonism versus single-pathway analogues like Semaglutide.
• Peptide engineering – examining structure-activity relationships and half-life extension strategies in peptides.

Tirzepatide’s dual activity has made it a widely referenced compound in non-clinical research, providing a model for exploring multi-pathway receptor engagement.

Product Specifications

Peptide: Tirzepatide (synthetic 39-amino-acid peptide)

Quantity: 40 mg per vial (lyophilized powder)

Purity: ≥99% (HPLC verified, MS-confirmed)

Other Names: LY3298176 (research code name)

CAS Number: 2023788-19-2

Form: Lyophilized powder (white, sterile)

Storage: Store at –20°C in a dry, dark place for long-term stability. (Reconstituted solutions should be refrigerated at 2–8°C and used within 4 weeks.)

Handling: Reconstitute with sterile laboratory solvents suitable for peptide research. Gently swirl to dissolve; do not shake vigorously.

Use: For research and laboratory use only. Not for human or veterinary use.

Frequently Asked Questions

Q: How does Tirzepatide differ from Semaglutide in research?

A: Semaglutide is a GLP-1 selective agonist, while Tirzepatide activates both GLP-1 and GIP receptors. This dual action provides researchers with the ability to study overlapping and distinct signaling effects in metabolic pathways, making it useful for comparative investigations.

Q: What are the main research applications of Tirzepatide?

A: Tirzepatide is used in laboratory settings to study incretin biology, dual receptor pharmacology, and structure-function relationships in peptide research. All applications are strictly preclinical and investigational.

Q: Does Tirzepatide 40mg need to be reconstituted?

A: Yes. Tirzepatide 40mg is provided as a lyophilized powder. It should be reconstituted with an appropriate sterile solvent for research use. Always follow standard laboratory handling procedures, avoid repeated freeze-thaw cycles, and aliquot reconstituted solutions for consistency.

Q: Is Tirzepatide 40mg intended for human or veterinary use?

A: No. Tirzepatide from BulkGLP is supplied strictly for laboratory and research purposes only. It is not intended for human consumption, medical, or veterinary applications.

Ready to Advance Your Research?

Strengthen your incretin research with Tirzepatide 40mg from BulkGLP. Each vial is third-party verified for purity and consistency, providing reliable material for laboratory studies. Order today and access high-quality research-grade peptides supported by rigorous testing and rapid delivery.